From Vial to Certificate: Keeping Label References and CoAs Aligned in a Changing SOP

Updating a laboratory SOP is rarely just a wording exercise. When a procedure covers receipt, storage or in-vitro preparation of research materials, the revision must preserve a defensible trail from the physical vial label to the corresponding Certificate of Analysis (CoA). The label reference is often the first unique key at goods-in; the CoA supports batch-level identity, purity and testing information. If the SOP does not define how those records are matched, tidy paperwork can point to the wrong vial or document version. Materials supplied for this work are strictly for controlled laboratory and analytical research; they are not medicines, medical devices, injectables, treatments or food supplements under UK law, and they are not for human or veterinary use.

Build a controlled reference map before rewriting the SOP

Before changing any step, the SOP owner should map the language already used on labels, CoAs, goods-in records and storage inventories. Research Sciences vial labels use a reference format combining SKU code and expiry date, for example BPC10-03/27, intended to link to the corresponding CoA. The SOP should define this string as the primary label reference and require comparison of product name, SKU, label reference, expiry date, supplier, CoA file name, CoA report identifier and reviewer initials. This prevents matching only the product name while overlooking the expiry segment or batch-specific certificate. Research Sciences describes batch-level analytical verification supporting purity, identity and contaminant screening, and states that every compound includes a CoA for HPLC purity and identity. The reviewer should open the actual CoA accompanying the specific batch.

The homepage lists “CoAs Janoshik Analytical Reports”; that is a pointer to the document set, not a substitute for checking the certificate for the batch in hand. Where heavy-metal or endotoxin evaluation is reported, capture the report reference and method exactly as stated, without inventing limits. Site-level wording such as “≥99% Verified Purity” is for orientation only; exact purity and identity should be read from the batch CoA and reconfirmed against current published wording.

Separate label reference, ITR and production-lot language

A robust SOP will not use “batch number”, “ITR” and “label reference” as interchangeable terms. The supplier FAQ notes that restocked products may carry the same Internal Test Reference as earlier stock. An ITR links to associated sample testing reports; it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. Record the ITR where it appears, but do not treat ITR equality as proof that two vials are analytically identical. For UK laboratories that source Uk peptides and related research materials, the revision should also state how legacy brand names are handled. Research Sciences is the current site name, while some pages and older posts still use Imperial Sciences UK or Imperial Peptides UK; the FAQ describes Research Sciences as the parent company and Imperial Peptides UK as a brand that continues to operate. That brand relationship belongs in a controlled mapping note, not in the analytical comparison itself.

Write the matching procedure as an auditable laboratory workflow

At goods-in, the materials manager should compare the physical label against the CoA record before the vial is moved to storage. Product name, SKU, label reference, expiry date and physical form should be consistent across label, order record and CoA. The CoA should be opened from the controlled document store, not an unverified desktop copy. If the CoA file name uses a different convention, record a cross-reference note rather than renaming the source document. Any mismatch—wrong SKU, different expiry segment, missing CoA, illegible label or conflicting product description—should trigger a hold state. The vial should be segregated, the discrepancy logged, and the supplier contacted with the label reference quoted exactly as printed. Research Sciences states that the reference should be quoted when contacting the shop about documentation.

Document the check, not just the outcome

A tick box saying “CoA checked” is weak evidence; a line entry recording the label reference, CoA report identifier, reviewer initials, date, storage location and any deviation is auditable. The record should state whether the CoA was reviewed for identity, purity and any contaminant screening listed for that batch. In an electronic notebook or inventory system, the label reference should be searchable, not free text. For damaged labels, require second-person verification against delivery paperwork and supplier documentation before transcription. All handling remains in-vitro laboratory workflow only, and the materials are not for human or veterinary use.

Restocks and packaging variation deserve their own sub-step. The FAQ notes that vial cap colours and other packaging may vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin. The SOP should prohibit using cap colour as a matching criterion. If a restock carries the same ITR as earlier stock, open the CoA associated with the current delivery and record any supplier documentation note; do not assume ITR equality means same production lot or separate independent testing. Storage instructions should also be checked against published guidance: lyophilised materials are described as stored at −20°C or below, sealed with desiccant and protected from moisture, heat and light; reconstituted materials are described as less stable and stored at 2–8°C for short-term laboratory use, with repeated freeze–thaw cycles avoided.

Train, version-control and audit the label-to-CoA check

The SOP update should make the matching procedure survive staff changes and supplier updates. It should name the roles responsible for goods-in verification, CoA retrieval, storage transfer and deviation review. Training records should show that each person has practised a live or simulated match using the label reference. A competency check can ask the trainee to locate a CoA from a label reference, identify a deliberate expiry-date mismatch and explain why cap colour is irrelevant. The SOP should define how often the reference map is reviewed and what triggers an out-of-cycle revision: a change in supplier label format, a new CoA layout, a restock with a shared ITR, a brand-name change or a documentation discrepancy. Where older pages use Imperial Sciences UK or Imperial Peptides UK, include a brand-mapping note rather than forcing staff to guess which record is current.

Version control should be visible in both the SOP and the CoA file structure. State which document is authoritative, where the controlled CoA is stored, and how superseded copies are marked. Require the reviewer to reconfirm any published supplier figure against the live site and the batch CoA at the point of review. Site-level purity claims and any delivery or order figures in marketing copy are published statements that can change, not permanent analytical specifications. The batch CoA remains the document to read for the specific vial. The SOP should also require research-use-only labelling and handling, consistent with the supplier’s stated position that products are labelled “For Research Use Only – Not for Human Consumption”. The laboratory remains responsible for lawful use, safe handling, storage, disposal and COSHH compliance, and for checking suitability for the intended in-vitro application.

A practical audit trail can be simple: a monthly sample of five vials, checked from label reference to CoA to storage record; a quarterly review of deviations; and a documented review whenever supplier label wording or documentation changes. The audit should look for missing expiry segments, copy-pasted CoA references, unmatched ITRs and free-text entries that cannot be searched. Any vial that cannot be matched to a CoA should be held outside the active inventory until the supplier confirms the documentation. The materials are not for human or veterinary use, and the SOP should make that boundary unambiguous for everyone who opens the storage cabinet.